Andres Elia
0000-0003-0766-3838
7 papers found
Refreshing results…
Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1
Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
Synthesis and Characterization of New Silica-Titania Mixed Oxides Obtained by Sol-Gel Technique
Missing publications? Search for publications with a matching author name.